Study of tenetic profiling and immune response of thoracic and solid cancers using clinical specimens

Study of tenetic profiling and immune response of thoracic and solid cancers using clinical specimens - Genetic profiling and immune response of thoracic and solid cancers

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023259

Enrollment

500

Registered

2016-07-21

Start date

2015-07-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are treated by any anti-cancer therapy in our institution. Patients who have at leas one specimen to analyze Patients who agreed to this study

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Response to treatment by RECIST	—

Secondary

Measure	Time frame
Safety (evaluated by CTCAE)	—

Countries

Japan

Contacts

Public ContactYasushi Goto

National Cancer Center Hospital Thoracic Oncology

ygoto@ncc.go.jp03-3542-2511

Outcome results